MX2010003511A - Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano. - Google Patents

Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano.

Info

Publication number
MX2010003511A
MX2010003511A MX2010003511A MX2010003511A MX2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A
Authority
MX
Mexico
Prior art keywords
cells
umbilical cord
optimized
isolation
precursor cells
Prior art date
Application number
MX2010003511A
Other languages
English (en)
Spanish (es)
Inventor
Rita Isabel Ganchas Soares
Maria Constanca Baptista Coelho
Jorge Miguel Silva Santos
Pedro Estilita Da Cruz
Jose Paulo Martins
Vera Alexandra Basto
Helder Joaquim Soares Da Cruz
Original Assignee
Medinfar Produtos Farmaceutico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinfar Produtos Farmaceutico filed Critical Medinfar Produtos Farmaceutico
Publication of MX2010003511A publication Critical patent/MX2010003511A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
MX2010003511A 2007-10-04 2008-10-03 Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano. MX2010003511A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT103843A PT103843B (pt) 2007-10-04 2007-10-04 Método de isolamento de células precursoras a partir do cordão umbilical humano
PCT/IB2008/054067 WO2009044379A2 (en) 2007-10-04 2008-10-03 Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord

Publications (1)

Publication Number Publication Date
MX2010003511A true MX2010003511A (es) 2010-09-10

Family

ID=40456372

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003511A MX2010003511A (es) 2007-10-04 2008-10-03 Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano.

Country Status (15)

Country Link
US (1) US9546353B2 (enExample)
EP (1) EP2203555B1 (enExample)
JP (1) JP5785394B2 (enExample)
KR (1) KR20100087705A (enExample)
CN (1) CN101868536B (enExample)
AU (1) AU2008306442B2 (enExample)
BR (1) BRPI0817522A2 (enExample)
CA (1) CA2701907A1 (enExample)
EA (1) EA025532B1 (enExample)
ES (1) ES2582369T3 (enExample)
IL (1) IL204788A (enExample)
MX (1) MX2010003511A (enExample)
PT (1) PT103843B (enExample)
WO (1) WO2009044379A2 (enExample)
ZA (1) ZA201002260B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2634545T3 (es) 2010-06-01 2017-09-28 Auxocell Laboratories, Inc. Células madre nativas de la gelatina de Wharton y su purificación
US9234177B2 (en) 2010-10-18 2016-01-12 Sunshine Life Science & Technology Corp. Human multipotent embryonic stem cell-like progenitor cells
TWI535377B (zh) * 2011-09-01 2016-06-01 Storage, culture and application of umbilical cord tissue and its derived cells
ES2890126T3 (es) * 2011-12-30 2022-01-17 Amit Patel Métodos y composiciones para la obtención clínica de una célula alogénica y usos terapéuticos
CN102550543B (zh) * 2012-02-10 2014-04-16 四川新生命干细胞科技股份有限公司 用于保存脐带组织的液体
CN103461322B (zh) * 2012-06-07 2016-08-03 西比曼生物科技（上海）有限公司 用于冻存复苏后的细胞的保存液
EP2756754B1 (de) 2013-01-17 2017-01-04 Vita 34 Ag Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
WO2015181831A2 (en) * 2014-05-24 2015-12-03 Venkataramanaa Neelamkrishnan A method for targettingglioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord
JP2017533917A (ja) * 2014-11-05 2017-11-16 ティッシュテック，インク． 神経成長および再生を促進するための組成物および方法
WO2017004460A1 (en) * 2015-06-30 2017-01-05 Surgenex, LLC Compositions and methods for flowable allograft tissue
WO2017096611A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带华通氏胶组织中分离培养脐带间充质干细胞的方法
WO2019175773A1 (en) 2018-03-12 2019-09-19 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
CN112342191A (zh) * 2019-08-07 2021-02-09 路春光 hMSC生产试剂盒开发和质量管理标准优化和体系建立
CN111893092A (zh) * 2020-06-28 2020-11-06 国大生命科学产业集团(深圳)有限公司 一种人脐带来源的间充质干细胞及其制备方法
CN113025567A (zh) * 2021-03-31 2021-06-25 中国人民解放军陆军特色医学中心 一种椎间盘单细胞的分离方法
DE102021116694B4 (de) * 2021-06-29 2023-03-09 Promocell Gmbh Wässrige Lösung zur Zellkonservierung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402890B (de) * 1994-03-16 1997-09-25 Berbi Gmbh Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln
JPWO2003080822A1 (ja) * 2002-03-27 2005-07-28 ニプロ株式会社 胎盤由来の間葉系細胞およびその医学的用途
CA2633980A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
ES2524443T3 (es) * 2006-11-13 2014-12-09 DePuy Synthes Products, LLC Expansión in vitro de células postparto usando microportadores

Also Published As

Publication number Publication date
JP2010539970A (ja) 2010-12-24
JP5785394B2 (ja) 2015-09-30
AU2008306442B2 (en) 2014-12-04
EP2203555A2 (en) 2010-07-07
ZA201002260B (en) 2011-06-29
ES2582369T3 (es) 2016-09-12
EA201000425A1 (ru) 2010-10-29
KR20100087705A (ko) 2010-08-05
IL204788A (en) 2013-07-31
EP2203555B1 (en) 2016-04-13
US20100216237A1 (en) 2010-08-26
CN101868536B (zh) 2015-03-25
PT103843A (pt) 2008-01-09
PT103843B (pt) 2008-08-12
CA2701907A1 (en) 2009-04-09
US9546353B2 (en) 2017-01-17
WO2009044379A2 (en) 2009-04-09
EA025532B1 (ru) 2017-01-30
WO2009044379A3 (en) 2009-05-22
CN101868536A (zh) 2010-10-20
IL204788A0 (en) 2010-12-30
AU2008306442A1 (en) 2009-04-09
BRPI0817522A2 (pt) 2014-10-14

Similar Documents

Publication Publication Date Title
MX2010003511A (es) Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano.
Neri et al. Molecular mechanisms contributing to mesenchymal stromal cell aging
ES2544967T3 (es) Formulación y método para la prevención y el tratamiento de las metástasis óseas o de otras enfermedades óseas
Yoon et al. Thermosensitive, stretchable, and piezoelectric substrate for generation of myogenic cell sheet fragments from human mesenchymal stem cells for skeletal muscle regeneration
BRPI0817911B8 (pt) Processos para transferência de substâncias moleculares para dentro de células vegetais e processo para expressão de um gene
Jian et al. Bioinspired self‐growing hydrogels by harnessing interfacial polymerization
WO2008073635A3 (en) Automatable artificial immune system (ais)
EP3190180A3 (en) A method for identifying, expanding, and removing adult stem cells and cancer stem cells
WO2007108835A3 (en) Automatable artificial immune system (ais)
SV2011003888A (es) Compuestos que expanden las celulas madre hematopoieticas
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
HK1203219A1 (en) Method of treatment employing therapeutic t cell product from mobilised donors
WO2014186469A3 (en) Human application of engineered chimeric antigen receptor (car) t-cells
WO2012048093A3 (en) Enhanced msc preparations
BR112012021267A2 (pt) métodos para a preparação de melanócitos a partir de células tronco humanas pluripotentes.
MX2018010529A (es) Composiciones y metodos para la produccion y administracion de acido ribonucleico.
BRPI0620946A8 (pt) anticorpo il-23p19 isolado, composição, método in vitro, artigo de fabricação, molécula e vetor de ácido nucleico, célula hospedeira procariótica
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
NZ630598A (en) Method of engrafting cells from solid tissues
EP4338803A3 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
NZ593365A (en) Pharmaceutical preparation comprising a blood mononuclear cell culture
AR053827A1 (es) Composiciones de tigeciclina y metodos de preparacion
WO2020107002A3 (en) Methods for expansion of natural killer (nk) cell subset and related compositions and methods
Mestre et al. 3D-bioengineered model of human skeletal muscle tissue with phenotypic features of aging for drug testing purposes
AR080816A1 (es) Preparacion derivada de un cultivo in vitro de celulas de argan no evocadas desdiferenciadas, su uso para el tratamiento del envejecimiento, la inflamacion y curacion de la piel, y metodo para su obtencion

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration